RE:Would symptomatic have been a better test goal?I don't think that would be a better path..... Sona is doing everything right. Their test is for asymptomatic people.......Things take time , and patience is all that is required now.....in the grand scope of things, a year from now, would you be better off owning a company that released an asymptomatic test in December, or a symptomatic test in August?............I think we both will come to the same conclusion.... Patience is all that is needed now...... Cheers!
jenkinjt wrote: Just wondering if SONA had aimed for the symptomatic market if they would have been a shoe in for approval. The nanotest is so sensitive at low viral levels I would think the sensitivity on symptomatic persons would be close to 100%. Is Quidels test for symptomatic? Still a big market and could work on improving the test for eventual home use for asymptomatic individuals (need >90% sensitivity without a health care provider to direct....would a pharmacist work?).